Genomics & Genetics Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genomics & Genetics Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Non-resectable colorectal hepatic metastases treated with alternating therapy
July 14th, 2006
Recent research from South Korea has chronicled the effects of hepatic arterial infusion (HAI) alternating with systemic chemotherapy in patients with non-resectable hepatic metastases from colorectal cancer. "HAI chemotherapy has a number of limitations, including a low rate of complete response and frequent extrahepatic recurrence, in colorectal cancer patients with non-resectable hepatic metastases," wrote J.C. Kim and colleagues, University of Ulsan. They explained, "Twenty-nine colorectal cancer patients with non-resectable hepatic metastases were consecutively enrolled for HAI alternating with systemic chemotherapy (HA + SC group). The protocol...
Source: Genomics & Genetics Weekly (2006-07-14)
|
